TCL Archive FDA Approves Abraxane For Second-Line Treatment Of Metastatic Breast Cancer January 28, 2005
TCL Archive DCCR Cancer Information Systems Program Renewed For Three More Years; Two Dropped, Two Added September 1, 1978